{"DataElement":{"publicId":"7736594","version":"1","preferredName":"Tumor Clinical N Stage","preferredDefinition":"The extent of nodal involvement of cancer as determined prior to treatment based on evidence obtained from clinical assessment parameters (physical examination, imaging, endoscopy, biopsy, surgical exploration, etc.).","longName":"RSORRES_NSTAGE","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"7736590","version":"1","preferredName":"Disease Response Domain Clinical N Category","preferredDefinition":"A domain for disease response evaluations._Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","longName":"6608777v1.0:2428496v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"6608777","version":"1","preferredName":"Disease Response Domain","preferredDefinition":"A domain for disease response evaluations.","longName":"C107097","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease Response Domain","conceptCode":"C107097","definition":"A domain for disease response evaluations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7F6DD03A-0CB9-71AE-E053-F662850AB42C","latestVersionIndicator":"Yes","beginDate":"2019-01-14","endDate":null,"createdBy":"TAYLORT","dateCreated":"2019-01-14","modifiedBy":"ONEDATA","dateModified":"2019-01-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428496","version":"1","preferredName":"Clinical N Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25398:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0888-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6F16A8B-6B1A-11D9-E053-4EBD850ADE59","latestVersionIndicator":"Yes","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ZHANGWE","dateModified":"2021-07-13","changeDescription":"07/12/2021 created for Theradex_TI","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7736593","version":"1","preferredName":"N Category Stage","preferredDefinition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement._The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"7736593v1.0","context":"Theradex","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"200","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N3","valueDescription":"N3 Stage Finding","ValueMeaning":{"publicId":"3202498","version":"1","preferredName":"N3 Stage Finding","longName":"3202498","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N3 TNM Finding","conceptCode":"C48714","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0E19-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F021F9-19A6-4CD0-E053-4EBD850AC6D3","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"N2","valueDescription":"N2 Stage Finding","ValueMeaning":{"publicId":"3202495","version":"1","preferredName":"N2 Stage Finding","longName":"3202495","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes. The definition of N2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4-9 axillary lymph nodes; for cutaneous melanoma it refers to metastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4 or more regional lymph nodes; and for bladder cancer it refers to metastases in multiple regional lymph nodes in the true pelvis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N2 TNM Finding","conceptCode":"C48786","definition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes. The definition of N2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4-9 axillary lymph nodes; for cutaneous melanoma it refers to metastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4 or more regional lymph nodes; and for bladder cancer it refers to metastases in multiple regional lymph nodes in the true pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0DAC-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F021F9-19B1-4CD0-E053-4EBD850AC6D3","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"N1","valueDescription":"N1 Stage Finding","ValueMeaning":{"publicId":"3202491","version":"1","preferredName":"N1 Stage Finding","longName":"3202491","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N1 TNM Finding","conceptCode":"C48706","definition":"A general term that refers to a TNM finding of cancer metastases usually in a limited number of regional lymph nodes. The definition of N1 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to micrometastases or metastases in 1-3 axillary lymph nodes; for cutaneous melanoma it refers to metastasis in 1 regional lymph node; for colorectal cancer it refers to metastases in 1-3 regional lymph nodes; and for bladder cancer it refers to metastasis in 1 regional lymph node in the true pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0D1A-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F021F9-19BC-4CD0-E053-4EBD850AC6D3","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"N0","valueDescription":"N0 Stage Finding","ValueMeaning":{"publicId":"3202490","version":"1","preferredName":"N0 Stage Finding","longName":"3202490","preferredDefinition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N0 TNM Finding","conceptCode":"C48705","definition":"A regional lymph node TNM finding indicating that there is no evidence of regional lymph node metastasis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0CF7-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"GDEEN","dateModified":"2023-02-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F021F9-19C7-4CD0-E053-4EBD850AC6D3","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"Nx","valueDescription":"NX Stage Finding","ValueMeaning":{"publicId":"3202502","version":"1","preferredName":"NX Stage Finding","longName":"3202502","preferredDefinition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"NX TNM Finding","conceptCode":"C48718","definition":"A regional lymph node TNM finding indicating that the status of regional lymph nodes cannot be assessed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9E2724CD-0EAB-2CEC-E040-BB89AD437A31","latestVersionIndicator":"Yes","beginDate":"2011-03-10","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-03-10","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"C6F021F9-19DB-4CD0-E053-4EBD850AC6D3","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","deletedIndicator":"No"},{"value":"N2-3","valueDescription":"N2 Stage Finding N3 Stage Finding","ValueMeaning":{"publicId":"3812310","version":"1","preferredName":"N2 Stage Finding N3 Stage Finding","longName":"3812310","preferredDefinition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes. The definition of N2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4-9 axillary lymph nodes; for cutaneous melanoma it refers to metastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4 or more regional lymph nodes; and for bladder cancer it refers to metastases in multiple regional lymph nodes in the true pelvis.: A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N2 TNM Finding","conceptCode":"C48786","definition":"A general term that refers to a TNM finding of cancer metastases in several regional lymph nodes. The definition of N2 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 4-9 axillary lymph nodes; for cutaneous melanoma it refers to metastases in 2-3 regional lymph nodes; for colorectal cancer it refers to metastases in 4 or more regional lymph nodes; and for bladder cancer it refers to metastases in multiple regional lymph nodes in the true pelvis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N3 TNM Finding","conceptCode":"C48714","definition":"A general term that refers to a TNM finding of cancer metastases in multiple lymph nodes. The definition of N3 TNM finding depends on the specific type of cancer that it refers to; for example, for breast cancer it refers to metastases in 10 or more axillary lymph nodes; for cutaneous melanoma it refers to metastases in 4 or more regional lymph nodes; for gastric cancer it refers to metastases in 7 or more regional lymph nodes; and for bladder cancer it refers to metastases in common iliac lymph nodes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E1A2BE14-DB80-00DD-E040-BB89AD432252","latestVersionIndicator":"Yes","beginDate":"2013-07-16","endDate":null,"createdBy":"RUETERJ","dateCreated":"2013-07-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"DDB80218-08E8-3249-E053-4EBD850AC626","beginDate":"2022-04-28","endDate":null,"createdBy":"TAYLORT","dateCreated":"2022-04-28","modifiedBy":"ONEDATA","dateModified":"2022-04-28","deletedIndicator":"No"},{"value":"N+","valueDescription":null,"ValueMeaning":{"publicId":"2580772","version":"1","preferredName":"Positive Lymph Node","longName":"2580772","preferredDefinition":"Cancer that has spread to the lymph nodes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Positive Lymph Node","conceptCode":"C27296","definition":"The presence of metastatic cancer cells in a lymph node.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0891-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-09-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-09-06","modifiedBy":"ONEDATA","dateModified":"2006-09-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"E5F89C07-5F97-1254-E053-731AD00A674D","beginDate":"2022-08-11","endDate":null,"createdBy":"ZHWENDY","dateCreated":"2022-08-11","modifiedBy":"ZHWENDY","dateModified":"2022-08-11","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7736592","version":"1","preferredName":"N Category Stage","preferredDefinition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:The extent of a cancer in the body. Staging is usually based on the size of the tumor, whether lymph nodes contain cancer, and whether the cancer has spread from the original site to other parts of the body.","longName":"C25580:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6F021F9-197E-4CD0-E053-4EBD850AC6D3","latestVersionIndicator":"Yes","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ONEDATA","dateModified":"2021-07-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6F021F9-198F-4CD0-E053-4EBD850AC6D3","latestVersionIndicator":"Yes","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ZHWENDY","dateModified":"2022-08-11","changeDescription":"4/28/22 TL added 1 PV. 07/12/2021 created for Theradex_TI","administrativeNotes":"8/11/2022: added one PV per ticket#CADSR0001399.wz","unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"N Stage","type":"Preferred Question Text","description":"N Stage","url":null,"context":"Theradex"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C6F18FFF-2B27-31FD-E053-4EBD850A835D","latestVersionIndicator":"Yes","beginDate":"2021-07-12","endDate":null,"createdBy":"TITARENI","dateCreated":"2021-07-12","modifiedBy":"ZHWENDY","dateModified":"2022-08-11","changeDescription":"07/12/2021 created for Theradex_TI","administrativeNotes":"8/11/2022: removed the AQT accidently added.wz","unresolvedIssues":null,"deletedIndicator":"No"}}